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Introduction

56
Unlike conventional neurotransmitters that are released from presynaptic nerve process designated "eCB Ca+GPCR ".
76
In the hippocampus, eCB-mediated short-term depression of synaptic GABA release, release", instead of "eCB GPCR " they use "basal RER" "Receptor-activated ER", and instead of
86
"eCB Ca+GPCR " they use "Ca 2+ -assisted RER". There is no difference in the phenomena 87 themselves.)
88
Although modulation of synaptic transmission by eCB signaling is increasingly well for eCBs in activity-dependent synaptic refinement (Deshmukh et al. 2007 assay to determine and standardize protein levels in subsequent western blotting analyses.
191
Ten micrograms of protein from each animal were electrophoresed in separate lanes on an 8% DSI was calculated as follows: DSI (%) = (1-mean amplitude of three eIPSCs after 215 depolarization pulse/ mean amplitude of five eIPSCs before depolarization pulse) x 100%.
216
Values of two or three DSI trials were averaged to obtain a mean DSI in a given condition.
217
Normalized DSI (Norm. DSI) was calculated as [(DSI tested in drug(s) /control DSI) x 100%].
218
Data are expressed as mean ± SEM, and p values are calculated from Student's unpaired or 219 paired t-tests or one-way ANOVA followed by Newman-Keuls test for multiple comparisons,
220
with significance levels assessed at p < 0.05, p < 0.01 or p < 0.005, with two-tailed tests. electrophysiologically, we refer to the combination of both processes as "mobilization". To 237 examine whether eCB mobilization exhibits a developmental change, we first tested DSI by 238 giving cells 1-s long depolarizing voltage steps every 2 minutes through the whole-cell pipette.
239
However in the youngest cohort of animals (PN1-9) essentially no DSI could be observed in of carbachol (CCh, 5 µM) alone had almost no effect on the eIPSCs in either neonates or 286 juveniles (10 ± 7%, n = 7 in neonates; 9 ± 2%, n = 5, in juveniles; p = 0.86 to 22 ± 3%, n = 7, paired t-test, p = 0.07 in neonates and 19 ± 2% to 20 ± 3%, n = 12, paired t-342 test, p = 0.65, in juveniles in U73343; 15 ± 2% to 11 ± 6%, n = 8, paired t-test, p = 0.46 in 343 neonates and 15 ± 2% to 19 ± 4%, n = 8, paired t-test, p = 0.13 in juveniles in U73122). The 344 inactive analog, U73343, had no effect on the increase in DSI caused by DHPG either in 345 neonates (n = 15, p < 0.02 paired t-test; Fig. 5A ), or in juveniles (n = 10, p < 0.001; Fig. 5C ),
346
and as before, DHPG caused a greater increase in DSI in the juveniles (n=10) than in the 347 neonatal (n = 15) animals (p < 0.05, unpaired t-test). However, the active PLC inhibitor,
348
U73122 prevented the enhancement of DSI by DHPG in both neonates (n = 10, p = 0.9; Fig. 349 5B), and in juveniles (n = 8; p = 0.06, paired t-test, Fig. 5D ). Summary data are shown in Fig.   350 5E. 3M3FBS, and observed that it had no effect on DSI in neurons recorded from either neonates 
3M3FBS-treated group). The higher concentration of m-3M3FBS (100 μM) had no further
364 effect in juveniles (data not shown).
365
We then tested the ability of PLC enhancement to affect eCB Ca+GPCR . DHPG continued 4% to 54 ± 7% (n = 5, p < 0.01, paired t-test, Figs. 7H, I ). These results are consistent with the 375 hypothesis that DHPG and m-3M3FBS act via a common pathway to increase eCB Ca+GPCR .
376
The differential effects of drugs acting on PLC support the conclusion that the developmental 377 increase in eCB Ca+GPCR is related to upregulation of this combined pathway. from the neonatal to the juvenile age ranges. In the older animals, the basal PLC activity 417 would be sufficient that its enhancement by the activator makes a noticeable contribution to the 418 net mobilization of eCBs, and thereby increases DSI. In the neonates, the basal PLC activity 419 may be so low that even increasing it does not make a measurable difference. On the other 420 hand, the low level of basal PLC activity in neonates will be moderately increased by an 421 mGluR agonist, and hence allow the PLC activator to boost eCB mobilization significantly. In 422 contrast, in the juveniles after mGluR stimulation, the PLC activity is apparently already 423 maximal, and therefore incapable of being further elevated by the PLC activator. Importantly,
424
there is no quantitative difference between maximally activated DHPG-enhanced DSI in 425 neonates (with the PLC activator) and juveniles (with or without the PLC activator), which is 426 consistent with a ceiling effect of PLC stimulation.
427
Our results suggest that m-3m3FBS potentiates the DHPG enhancement of DSI by 
437
Molecular mechanism of developmentally enhanced eCB Ca+GPCR -eCB and CB1R
438
The eCB responsible for most signaling processes, including eCB Ca, eCB GPCR, and 439 eCB Ca+GPCR, is 2-AG rather than anandamide (see Kano et al. 2009 , for review). PLC is 440 directly involved in the synthesis of 2-AG, whereas anandamide, which mediates eCB of these GPCRs affects CB1R levels. Finally, the PLC activator is unlikely to affect CB1R, but 457 had significant effects on eCBs mobilization. Thus the increase in GPCR-enhanced DSI is 458 most likely to be explained principally by increased eCB mobilization and not increased CB1R.
459
Lack of substantial changes in eCB Ca or eCB GPCR 
460
We found that, in the presence of agatoxin, DSI was greater in juveniles than in 461 neonates, but that the difference between the two groups was much reduced compared to found.
477
While we confirmed the developmental increase in DSI reported by Zhu and Lovinger
478
(2010), our data suggest that this may not be entirely attributed to a true increase in eCB Ca .
479
The developmental decrease in non-DSI-sensitive eIPSCs could have affected their results as 
Functional significance of increases in eCB Ca+GPCR
485
The synergistic interactions between DSI and mGluR or mAChR activation are probably se cannot be identified as the only mechanism.
499
However the molecular details of this issue are ultimately resolved, our demonstration 500 that development affects primarily the synergistic eCB Ca+GPCR pathway is itself quite significant.
501
Unlike the purely postsynaptic Ca 2+ -dependent eCB-mechanism, or the purely GPCR-502 dependent eCB-mechanism, the combined mechanism is equally dependent on both pre-and 503 post-synaptic factors. This means that it is ideally suited to take part in the formation and 504 shaping of critical neuronal circuitry, which requires coordinated presynaptic and postsynaptic 505 activity (Shatz 1990 
